Jul 10, 2008
FDA panel opposes Depakote warning
Advisers to the U.S. Food and Drug Administration on Thursday opposed a stepped-up warning about suicide risks from epilepsy drugs, including Abbott Laboratories' Depakote, saying a heightened alert might ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| FDA backs Abbott stent | Tue | Stent Lady | 1 |
| Had a knack for generating ideas | Aug 2 | Allison Youn... | 1 |
| Sugar in popular Similac Organic baby formula r... | Jul 31 | CBR | 7 |
| Abbott profit beats Wall Street estimates for 2Q | Jul '08 | Qamile Stema | 13 |
| FDA panel opposes Depakote warning | Jul '08 | Deeptoad | 1 |
| Mylan, Abbott settle anti-seizure drug dispute | Jun '08 | Jim | 1 |
| Abbott drugs in FDA risk reviews | Jun '08 | Corby | 2 |

